Julie Vetalice, Author at ORTHOWORLD

Arthrosurface OVO with Inlay Glenoid Total Shoulder Study Update

Study results indicate that use of Arthrosurface's OVO® with Inlay Glenoid Shoulder Arthroplasty System to treat glenohumeral OA yielded improved clinical outcomes, no reoperations or radiographic loosening and a high rate of return to activity.

Mar 12, 2020

NuVasive Attrax Putty Study Results

Orthobiologics ORTHOFLASH

Study results support the use of NuVasive's Attrax® Putty as a standalone bone graft substitute for autograft in instrumented thoracolumbar posterolateral lumbar fusion.

Mar 10, 2020

OrthoPediatrics Launches Large Fragment Cannulated Screw in U.S.

ORTHOFLASH Trauma

OrthoPediatrics commenced limited U.S. launch of the Large Fragment Cannulated Screw.

Mar 10, 2020

AAOS Cancels 2020 Annual Meeting in Face of COVID-19 Concerns

Competitive Landscape Market Drivers

The 2020 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) is canceled due to the ongoing spread of coronavirus. ORTHOWORLD wishes to reiterate our commitment to keep Members and subscribers apprised of the announcements to follow over the coming weeks.

Mar 10, 2020

Gramercy Extremity Orthopedics Secures $1 Million Revolving Line of Credit

Investments The Numbers

Gramercy Extremity Orthopedics entered into a new agreement for a $1 million revolving line of credit.

Mar 09, 2020

BioPoly Granted U.S. Patent for Implant Technology

Joint Replacement ORTHOFLASH

BioPoly was granted an additional U.S. patent for its partial resurfacing implants.

Mar 09, 2020

Medacta Gains FDA Clearance for Mecta-C Stand Alone ACIF Implant

ORTHOFLASH Spine

Medacta received FDA 510(k) clearance to market the Mecta-C Stand Alone Implant.

Mar 09, 2020

Episurf Medical Granted EU Patent for 3D Visualisation

ORTHOFLASH Robotics/Tech

Episurf Medical will receive a European patent addressing 3D visualization of joints.

Mar 06, 2020

DOJ Files Suit Against SpineFrontier

ORTHOFLASH Spine

The U.S. Department of Justice filed a suit against SpineFrontier, alleging payment of kickbacks to spine surgeons to induce use of SpineFrontier surgical devices.

Mar 06, 2020

Biogennix Gains Additional FDA Clearance for Agilon Moldable Bone Graft

Orthobiologics ORTHOFLASH

Biogennix received FDA 510(k) clearance to market Agilon™ moldable bone graft for use in posterolateral spine procedures when mixed with autograft.

Mar 05, 2020

Get the ORTHOWORLD Newsletter!

Contact Us